Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C BURNETT

Showing results (511-520 of 921) with videos related to

Pageof 93
Sort By:
European Journal of Heart Failure|April 1, 2015
Dietary sodium modulation of aldosterone activation and renal function during the progression of experimental heart failureWayne L Miller, Daniel D Borgeson, J Aaron Grantham, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2019
Tapping the therapeutic potential of protein tyrosine phosphatase 4A with small molecule inhibitorsNikhil R Tasker, Ettore J Rastelli, James C Burnett, et al.
Journal of Environmental Radioactivity|October 30, 2012
Tracking suspended particle transport via radium isotopes ((226)Ra and (228)Ra) through the Apalachicola-Chattahoochee-Flint River systemRichard N Peterson, William C Burnett, Stephen P Opsahl, et al.
Journal of the American College of Cardiology|November 6, 2012
Novel protein therapeutics for systolic heart failure: chronic subcutaneous B-type natriuretic peptideHorng H Chen, James F Glockner, John A Schirger, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|February 26, 2019
Exploring the "Preterm Behavioral Phenotype" in Children Born Extremely PretermAlice C Burnett, George Youssef, Peter J Anderson, et al.
Circulation. Heart Failure|August 13, 2011
Cardiorenal actions of TRV120027, a novel ß-arrestin-biased ligand at the angiotensin II type I receptor, in healthy and heart failure canines: a novel therapeutic strategy for acute heart failureGuido Boerrigter, Michael W Lark, Erin J Whalen, et al.
Psychological Medicine|July 8, 2011
Prevalence of psychiatric diagnoses in preterm and full-term children, adolescents and young adults: a meta-analysisA C Burnett, P J Anderson, J Cheong, et al.
Journal of Cardiac Failure|September 21, 2000
The role of coenzyme Q10 in the pathophysiology and therapy of experimental congestive heart failure in the dogA K Harker-Murray, A J Tajik, F Ishikura, et al.
Circulation|December 24, 2003
Endothelin A receptor antagonism in experimental congestive heart failure results in augmentation of the renin-angiotensin system and sustained sodium retentionJohn A Schirger, Horng H Chen, Michihisa Jougasaki, et al.
Kidney International|September 1, 1994
Presence of C-type natriuretic peptide in human kidney and urineM T Mattingly, R R Brandt, D M Heublein, et al.
Pageof 93

Showing results (511-520 of 921) with videos related to

Sort By:
Pageof 93
European Journal of Heart Failure|April 1, 2015
Dietary sodium modulation of aldosterone activation and renal function during the progression of experimental heart failureWayne L Miller, Daniel D Borgeson, J Aaron Grantham, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2019
Tapping the therapeutic potential of protein tyrosine phosphatase 4A with small molecule inhibitorsNikhil R Tasker, Ettore J Rastelli, James C Burnett, et al.
Journal of Environmental Radioactivity|October 30, 2012
Tracking suspended particle transport via radium isotopes ((226)Ra and (228)Ra) through the Apalachicola-Chattahoochee-Flint River systemRichard N Peterson, William C Burnett, Stephen P Opsahl, et al.
Journal of the American College of Cardiology|November 6, 2012
Novel protein therapeutics for systolic heart failure: chronic subcutaneous B-type natriuretic peptideHorng H Chen, James F Glockner, John A Schirger, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|February 26, 2019
Exploring the "Preterm Behavioral Phenotype" in Children Born Extremely PretermAlice C Burnett, George Youssef, Peter J Anderson, et al.
Circulation. Heart Failure|August 13, 2011
Cardiorenal actions of TRV120027, a novel ß-arrestin-biased ligand at the angiotensin II type I receptor, in healthy and heart failure canines: a novel therapeutic strategy for acute heart failureGuido Boerrigter, Michael W Lark, Erin J Whalen, et al.
Psychological Medicine|July 8, 2011
Prevalence of psychiatric diagnoses in preterm and full-term children, adolescents and young adults: a meta-analysisA C Burnett, P J Anderson, J Cheong, et al.
Journal of Cardiac Failure|September 21, 2000
The role of coenzyme Q10 in the pathophysiology and therapy of experimental congestive heart failure in the dogA K Harker-Murray, A J Tajik, F Ishikura, et al.
Circulation|December 24, 2003
Endothelin A receptor antagonism in experimental congestive heart failure results in augmentation of the renin-angiotensin system and sustained sodium retentionJohn A Schirger, Horng H Chen, Michihisa Jougasaki, et al.
Kidney International|September 1, 1994
Presence of C-type natriuretic peptide in human kidney and urineM T Mattingly, R R Brandt, D M Heublein, et al.
Pageof 93